Epigenetics in Drug Discovery

Country: United Kingdom

City: Cambridge

Abstr. due: 19.01.2016

Dates: 27.01.16 — 28.01.16

Area Of Sciences: Chemistry; Biology; Medicine; Pharmaceutics;

Organizing comittee e-mail: exhibitors@selectbio.com

Organizers: SelectBio

 

SELECTBIO is pleased to announce Epigenetics in Drug Discovery 2016, which will be held on 26 - 27 January 2016 in Cambridge, UK. The event is part of our Cambridge Workshop Series.    Attracting researchers, academics and industry professionals working in epigenetic research, this event will explore the potential of epigenetics to contribute towards novel and existing therapeutics, across significant areas of unmet need. Emerging technologies, epigenetic changes and cellular reprogramming will also be discussed, with special attention paid to drug discovery and development.    Viewed as a new frontier in drug discovery, rapid progress has been made in our understanding of epigenetic mechanisms of both new and existing drugs. With the processes that control epigenomic function providing new opportunities, epigenetics targets are enabling the discovery of novel drugs.    If you work in drug discovery research you will benefit from the expert knowledge of academic and industry leaders who are pushing the boundaries of epigenetics research, whilst networking with the technology providers who are enabling them to do so.   Agenda Topics   DNA Methylation Histone Modifications Next Generation Epitherapeutics Regulation of Genomic Functions

Conference Web-Site: http://selectbiosciences.com/conferences/index.aspx?conf=EGDD2016